Zimbabwe has been selected as one of only ten nations worldwide to introduce a revolutionary new form of prevention. The country will begin rolling out lenacapavir, an injectable medicine hailed as a significant breakthrough because it needs to be administered just twice a year.
This initiative is the result of a powerful collaboration between the United States pharmaceutical giant Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis, and Malaria. The news has been met with jubilation by health officials who have long battled the virus on the front lines.
The potential of this new treatment is staggering. Clinical trials have yielded exceptional results, offering a new beacon of hope.
ALSO READ: ‘Two Lives And US$1 Million Worth Of Properties Lost To Veld Fires Since July,’ EMA Reveals
A senior official from the Ministry of Health and Child Care confirmed the transformative nature of the development, stating,
“For decades, we’ve fought to turn the tide against this epidemic, and each day we get closer. In a large-scale clinical trial, more than 99% of people on lenacapavir remained HIV negative. While this has the potential to save millions of lives globally, here in Zimbabwe it represents a major step toward ending new infections.”
Zimbabwe Selected As One Of Ten Countries To Introduce The 6-Month HIV Prevention Injection
The rollout is designed to be more than just the distribution of a powerful new drug, it is a comprehensive strategy aimed at strengthening the entire healthcare framework. A key pillar of the plan involves prioritising the most vulnerable groups to break the chain of transmission for future generations.
The official elaborated on the multi-pronged approach, explaining,
“By focusing on pregnant and breastfeeding women, we’re protecting the next generation. By strengthening healthcare systems, we’re empowering Zimbabwe to lead its own fight against HIV. And by making lenacapavir more accessible, no one is left behind.”
ALSO READ: Gold Panner Gets 20 Years In Prison After Killing Friend Over A Monkey
The partnership ensures that the advanced medicine is provided at a significantly reduced cost, making it a sustainable and scalable solution within the national HIV prevention programme. This model of international cooperation is being hailed as a testament to what can be achieved when global leaders in science and development join forces with local expertise. The official concluded,
“This is American leadership at its best: driving innovation and building a world where children, mothers, and communities can thrive. Together, we’re not just fighting HIV-we’re winning.”
Follow Us on Google News for Immediate Updates
The post Zimbabwe Selected As One Of Ten Countries To Introduce The 6-Month HIV Prevention Injection appeared first on iHarare News.
